glp-1 agonists cardiovascular diseases Glucagon-like peptide 1 receptor agonists: benefits and mechanisms of action GLP-1 Receptor Agonists in Heart
Description
doi:10.1126/science.287.5453.664 67
showed that T2DM patients being treated with tirzepatide revealed lower MASH-related biomarkers and an increase in adiponectin, a cytokine beneficial in the regulation of glucose levels, lipid metabolism, and insulin sensitivity [10, 45, 46]
[DOI] [PMC free article] [PubMed] [Google Scholar] 160.Grieco G.E., et al
Stekovic, S
